glp-1 drug market news today Drugs Drop More Than Just Weight GLP-1 Receptor Agonist Market Size
Description
Opt for smaller, low-fat meals and steer clear of heavy or greasy foods, which can make nausea worse
Coverage for weight loss indications remains limited across most major plans
All five treatment groups had reductions in absolute body weight and BMI at 24 weeks, but the exenatide and dapagliflozin group had greater weight loss than those receiving only dapagliflozin or dapagliflozin and metformin ( P = .005)
M.TrautmannM.ZhuangD.et al (2008)
The results of each data bases search terms and keywords are shown in Table S1
Be sure to keep copies of everything for your records
